Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List (R)-3-(pyrrolidin-2-yl)pyridine

(R)-3-(pyrrolidin-2-yl)pyridine synthesis

9synthesis methods
-

Yield:-

Reaction Conditions:

with NADPHEnzymatic reaction;Reagent/catalyst;

Steps:

1 Example 1
Biotransformations were undertaken at 0.5 ml_ scale with a solution of 10mM myosmine and NADP+ (0.5mM), glucose (25 mM), glucose dehydrogenase (10U/ml), and the enzyme with imine reductase activity. The enzymes used are detailed in table 1 , available from Enzymicals. For each enzyme, the amount of enzyme was 9mg/ml of cell free extract (estimated approx. 0.9mg/ml contained enzyme). For IRED_B and IRED_C specifically, additional tests were run which used 0.9 mg/ml cell free extract. The enantiomeric excess of the (S) nornicotine obtained from the biotransformation was determined using a Chiralpak AD-FI column (250 x 4.6mm id) eluting with a mixture of hexane:ethanol:diethylamine 74.9 : 25.0: 0.1 (v/v/v) at 1 ml/min over 18 min at 30 °C. This method was also used to measure the conversion of myosmine into nornicotine, a relative response factor of 2.18 : 1 having been determined for uv absorption detection at 254 nm. The results are displayed in table 1 below. The % enantiomeric excess for (S)-nornicotine was identified according to the equation [(S)-(R)]/((S)+(R)] c 100 where (S) and (R) are the amounts of (S) and (R) enantiomers present respectively. The % conversion was identified according to the amount of myosmine consumed i.e. according to the equation 100- (final amount of myosmine)/(starting amount of myosmine) * 100.

References:

ZANOPRIMA LIFESCIENCES LIMITED;MCCAGUE, Raymond;NARASIMHAN, Ashok Srinivasan WO2020/98978, 2020, A1 Location in patent:Page/Page column 13

(R)-3-(pyrrolidin-2-yl)pyridine Related Search: